Resources and Insurance

Helpful NHL Support Resources

Many patient support groups offer helpful information about cancer. Some may also help you connect with a local support group. You can share your experiences and learn more about NHL. Many people find this helps them stay informed and stay positive.

Cancer organizations

American Cancer Society

www.cancer.org
1-800-ACS-2345 (1-800-227-23451-800-227-2345)
Call to learn more about your local ACS chapter.

CancerCare, Inc.

www.cancercare.org
1-800-813-HOPE (1-800-813-46731-800-813-4673)
They offer programs online and on the phone and referrals to local resources.

National Cancer Institute

www.cancer.gov
1-800-4CANCER (1-800-422-62371-800-422-6237)
Get information about NHL online and contact their support center by phone or live chat.

Lymphoma organizations

The Leukemia & Lymphoma Society

www.leukemia-lymphoma.org
1-800-955-45721-800-955-4572
Contact your local chapter for support, attend an educational program, and get NHL resources online.

Lymphoma Research Foundation

www.lymphoma.org
1-800-500-99761-800-500-9976
Get involved with your local chapter, attend an educational program, or get resources online.

Support organizations

Cancer Hope Network

www.cancerhopenetwork.org
1-877-HOPENET (1-877-467-36381-877-467-3638)
Cancer Hope Network can connect you with a support volunteer who was also diagnosed with and treated for cancer.

Cancer Support Community

www.cancersupportcommunity.org
1-888-793-WELL (1-888-793-93551-888-793-9355)
The Cancer Support Community offers support online and at several regional community centers.

Patient Advocate Foundation

www.patientadvocate.org
1-800-532-52741-800-532-5274
The Patient Advocate Foundation helps solve insurance and healthcare access issues. Their National Financial Resources Guidebook for Patients is a state-by-state directory of resources for patients seeking financial relief.

Clinical Trial Information

ClinicalTrials.gov

www.clinicaltrials.gov
Search for NHL clinical trials in the United States and around the world and get trial details, information about who may participate, locations, and contact information.

Online NHL support

Cancer Survivors Network—American Cancer Society

csn.cancer.org
1-800-ACS-23451-800-227-2345
An online support community for people living with cancer. Create your own page and connect with others via discussion boards and live chats.

CancerCare, Inc.

www.cancercare.org
1-800-813-HOPE1-800-813-4673
CancerCare also offers support groups and education workshops online.

Cancer Support Community

www.cancersupportcommunity.org
1-888-793-WELL1-888-793-9355
Cancer Support Community also offers online support groups, discussion boards, and an online space to create your online profile and journal to share with the community.

Daily Strength

www.dailystrength.org
Daily Strength offers online communities for people living with NHL and other conditions.

Genentech and Biogen Idec are not affiliated with any of these organizations. The information provided by Genentech, Biogen Idec, or these organizations is meant for informational purposes only. It is not meant to replace your physician's medical advice.

Next Section Glossary

Indications

RITUXAN® (Rituximab) is indicated for the treatment of patients with:

  • Previously untreated follicular, CD20-positive, B-cell NHL in combination with first-line chemotherapy and, in patients achieving a complete or partial response to RITUXAN in combination with chemotherapy, as single-agent maintenance therapy
  • Non-progressing (including stable disease), low-grade, CD20-positive, B-cell NHL, as a single agent, after first-line CVP chemotherapy
  • Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens
  • Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent

People with serious infections should not receive RITUXAN.

Important Safety Information

  • RITUXAN can cause serious side effects that can lead to death, including infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection).
  • RITUXAN has also been associated with serious and life-threatening side effects, including the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death.
  • The most common side effects of RITUXAN seen in patients with non-Hodgkin's lymphoma were infusion reactions, fever, chills, low white blood cells, infections, body aches, and tiredness. Before starting treatment with RITUXAN it is important to talk to your doctor about your medical history.
  • Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor.

Please see full Prescribing Information, including Medication Guide.

CVP=cyclophosphamide, vincristine, and prednisone or prednisolone; CHOP=cyclophosphamide, doxorubicin, vincristine, and prednisone.